Literature DB >> 27095876

Time to reconsider routine high-dose amoxicillin for community-acquired pneumonia in all Canadian children.

Nipunie Srimalie Rajapakse1, Joseph Varkey Vayalumkal1, Otto Gerben Vanderkooi2, Leah Jeanne Ricketson3, James Duncan Kellner2.   

Abstract

Entities:  

Year:  2016        PMID： 27095876      PMCID： PMC4807794          DOI： 10.1093/pch/21.2.65

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  16 in total

1.  Pneumococcal pneumonia and influenza: a deadly combination.

Authors:  Keith P Klugman; Yu-Wen Chien; Shabir A Madhi
Journal:  Vaccine       Date:  2009-08-21       Impact factor: 3.641

Review 2.  Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication.

Authors:  Malcolm Gillies; Anggi Ranakusuma; Tammy Hoffmann; Sarah Thorning; Treasure McGuire; Paul Glasziou; Christopher Del Mar
Journal:  CMAJ       Date:  2014-11-17       Impact factor: 8.262

3.  Etiology of community-acquired pneumonia in 254 hospitalized children.

Authors:  T Juvén; J Mertsola; M Waris; M Leinonen; O Meurman; M Roivainen; J Eskola; P Saikku; O Ruuskanen
Journal:  Pediatr Infect Dis J       Date:  2000-04       Impact factor: 2.129

4.  Community-acquired pneumonia requiring hospitalization among U.S. children.

Authors:  Seema Jain; Derek J Williams; Sandra R Arnold; Krow Ampofo; Anna M Bramley; Carrie Reed; Chris Stockmann; Evan J Anderson; Carlos G Grijalva; Wesley H Self; Yuwei Zhu; Anami Patel; Weston Hymas; James D Chappell; Robert A Kaufman; J Herman Kan; David Dansie; Noel Lenny; David R Hillyard; Lia M Haynes; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Richard G Wunderink; Kathryn M Edwards; Andrew T Pavia; Jonathan A McCullers; Lyn Finelli
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

5.  Etiology and treatment of community-acquired pneumonia in ambulatory children.

Authors:  L Wubbel; L Muniz; A Ahmed; M Trujillo; C Carubelli; C McCoig; T Abramo; M Leinonen; G H McCracken
Journal:  Pediatr Infect Dis J       Date:  1999-02       Impact factor: 2.129

6.  Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta.

Authors:  Jenine Leal; Otto G Vanderkooi; Deirdre L Church; Judy Macdonald; Gregory J Tyrrell; James D Kellner
Journal:  Pediatr Infect Dis J       Date:  2012-09       Impact factor: 2.129

7.  Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management.

Authors:  Nicole Le Saux; Joan L Robinson
Journal:  Paediatr Child Health       Date:  2015 Nov-Dec       Impact factor: 2.253

8.  Comprehensive detection of causative pathogens using real-time PCR to diagnose pediatric community-acquired pneumonia.

Authors:  Keiko Hamano-Hasegawa; Miyuki Morozumi; Eiichi Nakayama; Naoko Chiba; Somay Y Murayama; Reiko Takayanagi; Satoshi Iwata; Keisuke Sunakawa; Kimiko Ubukata
Journal:  J Infect Chemother       Date:  2008-12-17       Impact factor: 2.211

Review 9.  Optimizing antibacterial therapy for community-acquired respiratory tract infections in children in an era of bacterial resistance.

Authors:  Donald E Low; Michael E Pichichero; Urs B Schaad
Journal:  Clin Pediatr (Phila)       Date:  2004-03       Impact factor: 1.168

10.  Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries.

Authors:  Igor Rudan; Katherine L O'Brien; Harish Nair; Li Liu; Evropi Theodoratou; Shamim Qazi; Ivana Lukšić; Christa L Fischer Walker; Robert E Black; Harry Campbell
Journal:  J Glob Health       Date:  2013-06       Impact factor: 4.413
View more
  1 in total

Review 1.  Community-acquired pneumonia among children: the latest evidence for an updated management.

Authors:  Cristiana M Nascimento-Carvalho
Journal:  J Pediatr (Rio J)       Date:  2019-09-10       Impact factor: 2.197
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.